MedTrace Logo

" Visual Characterization of Parkinson's Patients and Oculomotor or Perceptual Therapy"

NCT06032130 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2026-05-04

No results posted yet for this study

Summary

Parkinson's disease (PD) is the second most common neurodegenerative condition worldwide, characterised by motor symptoms, but with other symptoms such as visual impairment.

The aim is to compare visual function between PD patients and healthy subjects in order to adequately characterise the visual capabilities of the PD population and perform oculomotor or perceptual therapy to find optometric solutions to slow down the visual impairment they suffer from or minimise their visual symptoms.

In the first phase, non-invasive tests will be carried out, such as measuring visual acuity, refraction, pupil diameter in different lighting conditions, sensory dominance, contrast sensitivity, colour vision, stereopsis, reading speed, binocular vision, eye movements and influence on quality of life.

In the second, visual oculomotor or perceptual exercises will be performed in a group of PD patients to assess whether there is stabilisation of impairment or improvement of these visual skills. These will be performed in a non-invasive way using simple and easy-to-use instruments or an application on an electronic device could be used.

Finally, in the third phase, those visual skills that have been treated will be re-evaluated to assess possible changes, compared with a group of PD patients who have not undergone the visual exercises.

Conditions

  • Parkinson Disease

Interventions

OTHER

Clinical measurements

Optometric measurements

OTHER

Oculomotor or perceptual therapy

Oculomotor or perceptual visual learning exercices

Sponsors & Collaborators

  • Asociación Parkinson Valencia

    collaborator OTHER

  • Hospital Arnau de Vilanova

    collaborator OTHER

  • University of Valencia

    lead OTHER

Principal Investigators

  • María Amparo Díez-Ajenjo, PhD · University of Valencia

Eligibility

Min Age
30 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-11-02
Primary Completion
2024-04-10
Completion
2026-04-08

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06032130 on ClinicalTrials.gov